MDMA-assisted therapy could get FDA approval as soon as January, top advocate predicts — but there’s a major problem looming

Source: New York Post

A drug once synonymous with rave culture could soon be making its way into a very different setting: the therapist’s office. A leading psychedelics advocate is “very optimistic” the Food and Drug Administration could approve MDMA-assisted therapy for post-traumatic stress disorder as early as January. But even if the treatment gets the green light, a major roadblock could stand between the psychedelic and the millions of Americans who could benefit from a new path to relief.